glp 1 perimenopause Microdosing GLP-1 in & Menopause ✨ Let's talk about microdosing GLP-1 during perimenopause & menopause ✨ If you've ever said: • “I'm eating the same but gaining weight” • “My cravings Is Perimenopause Blunting Your GLP-1?

Montvida, O., Green, J

Tirzepatide (Mounjaro, Zepbound) is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, not purely a GLP-1 agent

333 The expression of miR-124 is low in UC patients, and in vitro experiments have shown that the upregulation of miR-124 can promote a decrease in proinflammatory cytokines, including IL-17 and IL-6, as well as the chemokine CCL2, which plays a role in alleviating UC

They might help in a pinch, but long-term

For significant weight loss, prescription GLP-1 medications like semaglutide and tirzepatide have the strongest evidence

There was an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, nephrolithiasis, interstitial nephritis and drug-induced pancreatitis